Gavi Leap
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn more
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn moreGavi's five-year plan
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Latest news
View allGavi announces new partnerships to accelerate innovation and expand access to immunisation
New private-sector and philanthropic partnerships will help Gavi scale innovation, strengthen healthcare and reach underserved communities.
Gavi CEO calls for global health leap
Gavi CEO Dr Sania Nishtar, writing in The Lancet, sets out a framework for radical reform of global health institutions.
The Ministry of Health of the Kingdom of Cambodia announces the nationwide introduction of the rotavirus vaccine into the National Immunization Schedule, marking a significant milestone in protecting infants and young children from one of the…
What is VaccinesWork?
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn more
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn moreVaccinesWork latest
Measles killed thousands of Ugandan children, and then came the vaccine
“We have come a long way,” says one doctor, as a renewed wave of measles outbreaks threatens Uganda. “We simply cannot go back.”
After a year of challenges, Gavi can look forward with optimism
When the history of global health is written, it is likely that 2025 will be seen as a turning point.
New study validates previous conclusions supporting a single-dose HPV vaccination schedule
Findings demonstrate non-inferiority of one dose compared to two doses of HPV vaccines to prevent cervical cancer-causing HPV infections.
